Clin2
NCT07571733Possibly a fitNot yet recruiting

Spinal cord stimulation for severe restless legs syndrome

Restless Leg Syndrome (RLS)

Part of Brain & nervous system, Mental health clinical trials.

This study tests a device that sends mild electrical signals to the spinal cord to see if it can reduce severe restless legs syndrome symptoms when standard medicines haven't helped enough.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with restless legs syndrome (primary or secondary).
  • Your symptoms are severe (score over 20 on a standard severity scale).
  • You have had symptoms for at least 6 months.
  • Standard medicines haven't controlled your symptoms well enough, or you can't tolerate them.
  • You are willing to have a device implanted in your spine and follow the study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07780032Not yet recruiting
Spinal cord stimulation for severe restless legs syndrome

This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the spinal cord) can help reduce severe restless legs syndrome (RLS) symptoms that have not improved with medication. If you have severe RLS, this could be a new way to find relief.

Birmingham, Alabama
NCT07179406Recruiting
Spinal cord stimulators for restless leg syndrome

This study tests whether a spinal cord stimulator can help people with restless leg syndrome (RLS). It compares people with RLS to healthy volunteers to see if the device reduces symptoms.

Birmingham, Alabama
NCT07144631Recruiting
Nerve stimulation for restless legs in pregnancy

This trial tests if a small nerve stimulation device can safely and effectively reduce restless legs symptoms in pregnant people. If you are between 21 and 26 weeks pregnant with a confirmed diagnosis of restless legs syndrome (RLS), you may be eligible.

Providence, Rhode Island
NCT07453862Recruiting· Phase 1
New drug for restless legs syndrome: efficacy and safety study

This trial tests a new drug (a calcium channel modulator) to see how well it works and how safe it is for people with moderate to severe restless legs syndrome (RLS). It may offer a new treatment option for those with typical or variant RLS.

Beijing, Beijing Municipality
NCT07397247Not yet recruiting
Device therapy for restless legs syndrome with medication-related worsening

This study tests a wearable device that applies gentle electrical stimulation to the legs to reduce nighttime leg movements and improve sleep. It is for people with Restless Legs Syndrome whose symptoms have gotten worse after long-term use of dopamine medications.

Innsbruck, Tyrol
NCT05908214Recruiting
Electrical stimulation for leg stiffness and overactive nerves

This study tests a treatment using high-frequency electrical stimulation to reduce overactive nerve signals that can cause stiff legs, poor ankle control, cramps, or restless legs. It may help improve movement and comfort during walking or at night, depending on the condition.

Lausanne

Hear when a new Restless Leg Syndrome (RLS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.